The United States Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) for the Alkem Laboratories’ manufacturing facility located at Baddi, which was inspected from February 17, 2020 to February 21, 2020. The inspection has now been closed by the USFDA.
Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.
